India, May 14 -- An international panel has renamed polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS).

It has argued that the old term misrepresented the condition and focused too narrowly on ovaries.

The new name highlights multiple hormonal pathways, central metabolic dysfunction and broader systemic risks.

It is expected to improve diagnosis, communication and patient care, especially in countries like India with high metabolic disease burdens.

For decades, polycystic ovary syndrome (PCOS) has been recognised as one of the most common hormonal disorders affecting one in eight women worldwide. But scientists, researchers and patients have pointed out that the name fails to describe the true nature o...